Obesity Affects IVF Outcomes and Mevalonic Acid Rescues the Side Effects of Statins on Follicle Growth
The FASEB Journal · 15.07.2025 · 39 (13)
DOI: 10.1096/fj.202500914r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 27.06.2025. Verfasst von Fei Mao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Center of Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Mevalonic Acid, Obesity, Fertilization in Vitro, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Maternal and Child Health Scientific Research of Jiangsu Province, MOST | National Natural Science Foundation of China (NSFC), JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation).
Abstract (Originalsprache)
The accelerating trend of obesity in women of childbearing age has become a significant issue in personal health, female fecundity, and offspring development. Simvastatin (SV) is a statin commonly prescribed oral agent for lipid‐lowering therapy; however, its applicability in reproductively active women remains controversial. In this study, through clinical data analysis, we further confirmed that obesity reduces in vitro fertilization pregnancy success, with significant decreases in the number of retrieved oocytes, mature oocytes, and cleavage embryos. We found SV inhibited follicle development cultured in vitro. Based on our previously reported metabolomics data, mevalonic acid (MVA) was found to be a key metabolite in follicular development. In our in vitro follicle culture system, we demonstrated that the supplement of MVA in SV‐added follicles recovered to grow similar to the untreated blank group, indicating the rescue effect of potential reproductive toxicity of SV. Both the downstream metabolites cholesterol and geranylgeraniol partially attenuated SV‐induced apoptosis elevation and proliferation suppression in KGN cells. RNA sequencing results suggested that this rescue effect may be mediated through the TNF, PI3K‐Akt, and JAK–STAT pathways. Our study shed light upon clinical practice for women of childbearing age who were treated with statins and might contribute to better health management in obesity populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Center of Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
ORCID-Profile: Ruizhi Feng, Yun Qian
Förderung
- Maternal and Child Health Scientific Research of Jiangsu Province
- MOST | National Natural Science Foundation of China (NSFC)
- JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)
- Innovative and Entrepreneurial Team of Jiangsu Province (JSSCTD202144)
- Innovative and Entrepreneurial Talent Program of Jiangsu Province
- Project on Maternal and Child Health Talents of Jiangsu Province
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Mao, F., Yang, J., Guo, Z., Chang, T., Wu, H., Yang, G., Dai, H., Feng, R., & Qian, Y. (2025). Obesity Affects IVF Outcomes and Mevalonic Acid Rescues the Side Effects of Statins on Follicle Growth. The FASEB Journal, 39(13). https://doi.org/10.1096/fj.202500914r
Vancouver
Mao F, Yang J, Guo Z, Chang T, Wu H, Yang G, et al. Obesity Affects IVF Outcomes and Mevalonic Acid Rescues the Side Effects of Statins on Follicle Growth. The FASEB Journal. 2025;39(13). doi:10.1096/fj.202500914r
BibTeX
@article{Mao2025,
author = {Mao, Fei and Yang, Jihong and Guo, Zhihan and Chang, Tianqing and Wu, Hua and Yang, Guangping and Dai, Heqi and Feng, Ruizhi and Qian, Yun},
title = {Obesity Affects IVF Outcomes and Mevalonic Acid Rescues the Side Effects of Statins on Follicle Growth},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {13},
doi = {10.1096/fj.202500914r}
}
EUVIMED